Live Breaking News & Updates on Protara Therapeutics

Stay updated with breaking news from Protara therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DelveInsight Business Research, LLP: Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028

DelveInsight Business Research, LLP: Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , City Of , United Kingdom , Athira Pharma , Expressi Ontherapeutics , Eli Lilly , Transthera Biosciences , Prnewswire Delveinsight , Taizhou Hanzhong , Inmune Bio , Klus Pharma , Bristol Myers Squibb , Emtora Biosciences , Astellas Pharma , Shruti Thakur , Ocellaris Pharma , Takara Bio , Innocare Pharma , Merck Sharp Dohme , Asieris Pharmaceuticals , Online Services , Quadriga Biosciences Inc , Coya Therapeutics Inc , Biovie Inc , Fusion Pharmaceuticals , Nono Inc ,

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Update

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 77,700 shares, a drop of 28.5% from the July 15th total of 108,600 shares. Based on an average daily trading volume, of 34,000 […] ....

Virtu Financial , Protara Therapeutics Inc , Privium Fund Management United Kingdom Ltd , Protara Therapeutics Company Profile , Renaissance Technologies , Privium Fund Management , Protara Therapeutics , Get Free Report , Fund Management United Kingdom Ltd , Protara Therapeutics Daily , Nasdaq Tara ,

Short Interest in Protara Therapeutics, Inc. (NASDAQ:TARA) Decreases By 28.5%

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totalling 77,700 shares, a decline of 28.5% from the July 15th total of 108,600 shares. Approximately 0.9% of the shares of the stock are short sold. Based on an average […] ....

Virtu Financial , Protara Therapeutics Inc , Privium Fund Management United Kingdom Ltd , Privium Fund Management , Renaissance Technologies , Protara Therapeutics , Get Free Report , Fund Management United Kingdom Ltd , Protara Therapeutics Daily , Nasdaq Tara ,